TXNRD2, thioredoxin reductase 2, 10587

N. diseases: 134; N. variants: 31
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Generalized Thyroid Hormone Resistance
0.100 GeneticVariation disease BEFREE Resistance to thyroid hormone (RTH) is an autosomal dominant disorder that is caused by mutations in the thyroid hormone receptor beta (TR beta) gene. 7711514 1994
Generalized Thyroid Hormone Resistance
0.100 GeneticVariation disease BEFREE A new TRβ mutation in resistance to thyroid hormone syndrome. 28222413 2016
Generalized Thyroid Hormone Resistance
0.100 GeneticVariation disease BEFREE Here, we hypothesized that additional pathogenic mutations in TRβ are likely to exist in human population and analysed clinical cases with suspected RTH. 28557707 2017
Generalized Thyroid Hormone Resistance
0.100 GeneticVariation disease BEFREE We report here an illustrative case of a 29 year-old patient with RTH caused by a mutation in exon 9 (A317T) of TRβ gene, who presented multicentric papillary thyroid cancer. 22460197 2012
Generalized Thyroid Hormone Resistance
0.100 GeneticVariation disease BEFREE Taken together, these data suggest that the aberrant recruitment of NCOR1 by RTH TRβ mutants leads to clinical RTH in humans. 21987803 2011
Generalized Thyroid Hormone Resistance
0.100 GeneticVariation disease BEFREE A tight linkage between generalized resistance to thyroid hormone (GRTH) and the thyroid hormone receptor-beta (TR beta) gene is indicated. 1619012 1992
Generalized Thyroid Hormone Resistance
0.100 GeneticVariation disease BEFREE A 44-year-old Japanese woman with RTH, which was confirmed by the presence of a P453A mutation in the thyroid hormone receptor β (TRβ) gene, showed a slight elevation of the basal levels of thyroid hormones, which indicated that her pituitary RTH was mild. 23240983 2013
Generalized Thyroid Hormone Resistance
0.100 GeneticVariation disease BEFREE All subjects fulfilling the criteria of RTH (6 of family F94 and one of family F27) had the same point mutation in the T3-binding domain on one of the two alleles of the TR beta gene. 7833659 1994
Generalized Thyroid Hormone Resistance
0.100 GeneticVariation disease BEFREE Resistance to thyroid hormone (RTH) is an inherited defect manifesting as variable tissue hyporesponsiveness to thyroid hormone, usually caused by mutations in the thyroid hormone receptor beta (TR beta) gene. 9086568 1997
Generalized Thyroid Hormone Resistance
0.100 Biomarker disease BEFREE Generalized resistance to thyroid hormone (GRTH) is a disorder of thyroid hormone action which has been linked to the beta thyroid hormone receptor (TR beta) gene. 8187964 1994
Generalized Thyroid Hormone Resistance
0.100 GeneticVariation disease BEFREE Except for one family, point mutations so far described in RTH are clustered at exons 8-10 of the TR beta gene. 8563471 1995
Generalized Thyroid Hormone Resistance
0.100 GeneticVariation disease BEFREE We present a new family with RTH (F120) found to have a mutation R316H in the thyroid hormone receptor beta (TR beta) gene identical for that reported in an unrelated family. 8200958 1994
Generalized Thyroid Hormone Resistance
0.100 GeneticVariation disease BEFREE Defects in TRβ lead to RTH (resistance to thyroid hormone) β, a syndrome characterized by high levels of thyroid hormone and non-suppressed TSH (thyroid-stimulating hormone). 22220593 2012
Generalized Thyroid Hormone Resistance
0.100 GeneticVariation disease BEFREE Mice with mutations in the thyroid hormone receptor beta (TRβ) gene that cannot bind steroid receptor coactivator 1 (SRC-1) and Src-1(-/-) mice both have phenotypes similar to that of RTH. 24550004 2014
Generalized Thyroid Hormone Resistance
0.100 GeneticVariation disease BEFREE Seventeen patients presented mutations in TRβ (RTHβ); six were non-TR-RTH, three had a diagnosis of FDH with a mutation in ALB, and four were diagnosed with TPA. 30027432 2018
Generalized Thyroid Hormone Resistance
0.100 GeneticVariation disease BEFREE She was determined to harbor a missense mutation of M310T in exon 9 of the TR beta gene, and diagnosed with generalized RTH. 20808683 2010
Generalized Thyroid Hormone Resistance
0.100 GeneticVariation disease BEFREE TR beta gene mutations have been recently identified in 68 families with RTH. 7833674 1994
Generalized Thyroid Hormone Resistance
0.100 GeneticVariation disease BEFREE Mice with a knock-in mutation in the TRβ gene spontaneously develop TSHomas, although as yet no patient has been reported to have both a TSHoma and RTHβ. 25867808 2015
Generalized Thyroid Hormone Resistance
0.100 GeneticVariation disease BEFREE Sequence analysis of the TR beta gene from a patient with the syndrome of resistance to thyroid hormone revealed a novel missense mutation in exon 9, changing thymidine in position 1123 to cytosine. 9086569 1997
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.090 Biomarker group BEFREE With TRβ as a tumor suppressor and Runx2 as a tumor promoter, a compelling question is whether there is a functional relationship between these regulatory factors in thyroid tumorigenesis. 27253998 2016
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.090 AlteredExpression group BEFREE The thyroid hormone receptor TRβ increases NCoR expression and this induction is essential in mediating the anti-metastatic and tumor suppressive actions of the receptor. 27149915 2016
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.090 AlteredExpression group BEFREE Therefore, BRG1-mediated chromatin remodeling may be obligatory for TRβ transcriptional repression and tumor suppressor function in thyroid tumorigenesis. 29750276 2018
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.090 Biomarker group BEFREE The miRNAs reduced in TRα1/TRβ knockout mice are known to play crucial roles in epidermal proliferation, hair cycling, wound healing, stem-cell function, and tumor development, all processes altered in the absence of TRs. 29742977 2018
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.090 AlteredExpression group BEFREE Importantly, new vessel formation was significantly suppressed in tumors induced by FTC cells expressing TRβ compared with control FTC cells without TRβ. 23731250 2014
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.090 Biomarker group BEFREE These finding indicate that TRβ is a tumor suppressor and could be tested as a potential therapeutic target. 23183175 2013